Ackler S., Mitten M., Chen J., Clarin J., Foster K., Jin S. et al. 2012 Navitoclax (ABT-263) and bendamustine±rituximab induce enhanced killing of non-Hodgkin’s lymphoma tumours in vivo. Br. J. Pharmacol. 167, 881–891.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bailey J. K., Shen W., Liang X. .-h, Crooken S. T. and Liang.X.-h. and Crooke S. T. 2017 Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides. Nucleic Acids Res. 45, 10649–10671.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baumans V. 2004 Use of animals in experimental research: an ethical dilemma? Gene Ther. 11, S64–S66.

Article  CAS  PubMed  Google Scholar 

Bennett C. F. and Swayze E. E. 2010 RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol. 50, 259–293.

Article  CAS  PubMed  Google Scholar 

Birnkrant D. J., Ashwath M. L., Noritz G. H., Merrill M. C., Shah T. A., Crowe C. A. and Bahler R. C. 2010 Cardiac and pulmonary function variability in Duchenne/Becker muscular dystrophy: an initial report. J. Child. Neurol. 25, 1110–1115.

Article  PubMed  PubMed Central  Google Scholar 

Bustin S. A., Benes V., Garson J. A., Hellemans J., Huggett J., Kubista M. et al. 2009 The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611–622.

Article  CAS  PubMed  Google Scholar 

Chen Y., Cheng G. and Mahato R. I. 2008 RNAi for treating hepatitis B viral infection. Pharm. Res. 25, 72–86.

Article  CAS  PubMed  Google Scholar 

Crooke S. T., Wang S., Vickers T. A., Shen W. and Liang X.-h 2017 Cellular uptake and trafficking of antisense oligonucleotides. Nat. Biotechnol. 35, 230–237.

Article  CAS  PubMed  Google Scholar 

Crooke S. T., Vickers T. A. and Liang X.-h 2020 Phosphorothioate modified oligonucleotide–protein interactions. Nucleic Acids Res. 48, 5235–5253.

Article  PubMed  PubMed Central  Google Scholar 

Danesh Mesgaran M., Kargar H., Mesgaran S. D. and Javadmanesh A. 2021 Peripartal rumen-protected L-carnitine manipulates the productive and blood metabolic responses in high producing Holstein dairy cows. Front. Vet. Sci. 8, 1514.

Article  Google Scholar 

De Mesmaeker A., Altmann K.-H., Waldner A. and Wendeborn S. 1995 Backbone modifications in oligonucleotides and peptide nucleic acid systems. Curr. Opin. Struct. Biol. 5, 343–355.

Article  PubMed  Google Scholar 

Dobrovolskaia M. A. and McNeil S. E. 2015 Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics. Expert. Opin. Drug. Deliv. 12, 1163–1175.

Article  CAS  PubMed  Google Scholar 

Eilers W., Cleasby M. and Foster K. 2021 Development of antisense-mediated myostatin knockdown for the treatment of insulin resistance. Sci. Rep. 11, 1–10.

Article  Google Scholar 

Emery A. E., Muntoni F. and Quinlivan R. 2015 Duchenne muscular dystrophy. OUP Oxford.

Foster K., Graham I. R., Otto A., Foster H., Trollet C., Yaworsky P. J. et al. 2009 Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle. Rejuvenation Res. 12, 85–94.

Article  CAS  PubMed  Google Scholar 

Ghahramani Seno M. M., Graham I. R., Athanasopoulos T., Trollet C., Pohlschmidt M., Crompton M. R. and Dickson G. 2008 RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology. Hum. Mol. Genet. 17, 2622–2632.

Article  CAS  PubMed  Google Scholar 

Hagstrom J. E., Hegge J., Zhang G., Noble M., Budker V., Lewis D. L. et al. 2004 A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol. Ther. 10, 386–398.

Article  CAS  PubMed  Google Scholar 

Harb W. A., Lakhani N., Logsdon A., Steigelman M., Smith-Green H., Gaylor S. et al. 2014 The BCL2 targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 is active in patients with relapsed or refractory non-Hodgkin’s lymphoma. Blood 124, 1716.

Article  Google Scholar 

Huang Y., Snyder R., Kligshteyn M. and Wickstrom E. 1995 Prevention of tumor formation in a mouse model of Burkitt’s lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate. Mol. Med. 1, 647–658.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang J. K., Malerba A., Popplewell L., Foster K. and Dickson G. 2011 Antisense-induced myostatin exon skipping leads to muscle hypertrophy in mice following octa guanidine morpholino oligomer treatment. Mol. Ther. 19, 159–164.

Article  CAS  PubMed  Google Scholar 

Kaur H., Babu B. R. and Maiti S. 2007 Perspectives on chemistry and therapeutic applications of locked nucleic acid (LNA). Chem. Rev. 107, 4672–4697.

Article  CAS  PubMed  Google Scholar 

Kawai-Toyooka H., Kuramoto C., Orui K., Motoyama K., Kikuchi K., Kanegae T. and Wada M. 2004 DNA interference: a simple and efficient gene-silencing system for high-throughput functional analysis in the fern Adiantum. Plant Cell Physiol. 45, 1648–1657.

Article  CAS  PubMed  Google Scholar 

Kemaladewi D. U., Hoogaars W. M., van Heiningen S. H., Terlouw S., de Gorter D. J., den Dunnen J. T. et al. 2011 Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy. BMC Med. Genom. 4, 1–10.

Article  Google Scholar 

Khan T., Weber H., DiMuzio J., Matter A., Dogdas B., Shah T. et al. 2016 Silencing myostatin using cholesterol-conjugated siRNAs induces muscle growth. Mol. Thera-Nucleic AcidS. 5, e342.

Article  CAS  Google Scholar 

Kim K. M., Jang H. C. and Lim S. 2016 Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J. Inter. Med. 31, 643.

Article  Google Scholar 

Kinouchi N., Ohsawa Y., Ishimaru N., Ohuchi H., Sunada Y., Hayashi Y. et al. 2008 Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass. Gene. Thera. 15, 1126–1130.

Article  CAS  Google Scholar 

Koenig M., Hoffman E., Bertelson C., Monaco A., Feener C. and Kunkel L. 1987 Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509–517.

Article  CAS  PubMed  Google Scholar 

Ku S. H., Jo S. D., Lee Y. K., Kim K. and Kim S. H. 2016 Chemical and structural modifications of RNAi therapeutics. Adv. Drug. Deliv. Rev. 104, 16–28.

Article  CAS  PubMed  Google Scholar 

Laws N., Cornford-Nairn R. A., Irwin N., Johnsen R., Fletcher S., Wilton S. D. and Hoey A. J. 2008 Long-term administration of antisense oligonucleotides into the paraspinal muscles of mdx mice reduces kyphosis. J. Appl. Physiol. 105, 662–668.

Article  CAS  PubMed  Google Scholar 

Lu-Nguyen N. B., Jarmin S. A., Saleh A. F., Popplewell L., Gait M. J. and Dickson G. 2015 Combination antisense treatment for destructive exon skipping of myostatin and open reading frame rescue of dystrophin in neonatal mdx mice. Mol. Ther. 23, 1341–1348.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McPherron A. C. and Lee S.-J. 2002 Suppression of body fat accumulation in myostatin-deficient mice. J. Clin. Investig. 109, 595–601.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McPherron A. C., Lawler A. M. and Lee S.-J. 1997 Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member. NatUre 387, 83–90.

Article  CAS  PubMed  Google Scholar 

Napoli C., Christine L., Richard J., Lemieux C. and Jorgensen R. 1990 Introduction of a chimeric chalcone sy nthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2, 279–289.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parise G., McKinnell I. W. and Rudnicki M. A. 2008 Muscle satellite cell and atypical myogenic progenitor response following exercise. Muscle Nerve. 37, 611–619.

Article  CAS  PubMed  Google Scholar 

Peiris H., Lappas M., Georgiou H., Vaswani K., Salomon C., Rice G. and Mitchell M. 2015 Myostatin in the placentae of pregnancies complicated with gestational diabetes mellitus. Placenta. 36, 1–6.

Article  CAS  PubMed  Google Scholar 

Rappaport J., Hanss B., Kopp J. B., Copeland T. D., Bruggeman L. A., Coffman T. M. and Klotman P. E. 1995 Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy. Kidney Internat. 47, 1462–1469.

Article  CAS  Google Scholar 

Riasi M., Mozaffari Jovin S. and Javadmanesh A. 2022 Effect of Intramuscular and Intraperitoneal Injections of conjugated MSTN-siRNA-cholesterol on Inhibition of Myostatin Gene expression. J. Cell. Mol. Res. 14, 20–27.

CAS  Google Scholar 

Rodgers B. D. and Garikipati D. K. 2008 Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr. Rev. 29, 513–534.

Article  CAS  PubMed  PubMed Central